Suppr超能文献

肺部区域性通气变化:利用超极化气体 MR 成像作为定量生物标志物的治疗反应映射。

Regional Ventilation Changes in the Lung: Treatment Response Mapping by Using Hyperpolarized Gas MR Imaging as a Quantitative Biomarker.

机构信息

From the Unit of Academic Radiology, Department of Infection, Immunity and Cardiovascular Disease, C Floor, Royal Hallamshire Hospital, University of Sheffield, Glossop Rd, Sheffield S10 2JF, England (F.C.H., H.M., G.J.C., J.P., J.M.W.); Novartis, Basel, Switzerland (R.K.); Department of Respiratory Medicine, Glenfield Hospital, Leicester, England (S.S., C.E.B.); Insigneo Institute of In-Silico Medicine, University of Sheffield, Sheffield, England (J.M.W.).

出版信息

Radiology. 2017 Sep;284(3):854-861. doi: 10.1148/radiol.2017160532. Epub 2017 May 4.

Abstract

Purpose To assess the magnitude of regional response to respiratory therapeutic agents in the lungs by using treatment response mapping (TRM) with hyperpolarized gas magnetic resonance (MR) imaging. TRM was used to quantify regional physiologic response in adults with asthma who underwent a bronchodilator challenge. Materials and Methods This study was approved by the national research ethics committee and was performed with informed consent. Imaging was performed in 20 adult patients with asthma by using hyperpolarized helium 3 (He) ventilation MR imaging. Two sets of baseline images were acquired before inhalation of a bronchodilating agent (salbutamol 400 μg), and one set was acquired after. All images were registered for voxelwise comparison. Regional treatment response, ΔR(r), was calculated as the difference in regional gas distribution (R[r] = ratio of inhaled gas to total volume of a voxel when normalized for lung inflation volume) before and after intervention. A voxelwise activation threshold from the variability of the baseline images was applied to ΔR(r) maps. The summed global treatment response map (ΔR) was then used as a global lung index for comparison with metrics of bronchodilator response measured by using spirometry and the global imaging metric percentage ventilated volume (%VV). Results ΔR showed significant correlation (P < .01) with changes in forced expiratory volume in 1 second (r = 0.70), forced vital capacity (r = 0.84), and %VV (r = 0.56). A significant (P < .01) positive treatment effect was detected with all metrics; however, ΔR showed a lower intersubject coefficient of variation (64%) than all of the other tests (coefficient of variation, ≥99%). Conclusion TRM provides regional quantitative information on changes in inhaled gas ventilation in response to therapy. This method could be used as a sensitive regional outcome metric for novel respiratory interventions. RSNA, 2017 Online supplemental material is available for this article.

摘要

目的 利用超极化气体磁共振成像(MR)的治疗反应映射(TRM)评估肺部对呼吸治疗药物的区域性反应程度。TRM 用于量化接受支气管扩张剂挑战的哮喘成人的区域性生理反应。

材料与方法 本研究经国家伦理委员会批准,并获得患者知情同意。采用超极化氦 3(He)通气 MR 成像对 20 例哮喘成人进行成像。在吸入支气管扩张剂(沙丁胺醇 400μg)前采集两组基线图像,干预后采集一组。所有图像均进行配准以进行体素比较。通过比较吸入气体与标准化肺充气量的体素总容积的比值(R[r]),计算区域治疗反应(ΔR(r))。采用基线图像变异性的体素激活阈值应用于ΔR(r)图。然后将总和的全局治疗反应图(ΔR)用作与使用肺活量计和全局成像指标通气容积百分比(%VV)测量的支气管扩张剂反应的指标进行比较的全局肺指数。

结果 ΔR 与 1 秒用力呼气量(r = 0.70)、用力肺活量(r = 0.84)和%VV(r = 0.56)的变化显著相关(P <.01)。所有指标均检测到显著(P <.01)的治疗效果阳性,但与其他所有测试相比,ΔR 的受试者间变异系数较低(64%)(变异系数,≥99%)。

结论 TRM 提供了关于治疗反应中吸入气体通气变化的区域性定量信息。这种方法可作为新型呼吸干预的敏感区域性结果指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验